Viewing Study NCT05985694


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-02-04 @ 2:52 AM
Study NCT ID: NCT05985694
Status: COMPLETED
Last Update Posted: 2025-09-10
First Post: 2023-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
Sponsor: Advagene Biopharma Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Eosinophilic Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LTh(αK), Type I/III Interferon, Immunomodulator, epithelial View